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Abstract
The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or
diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It
is confirmed that higher blood pressure levels are associated with increased risk of cardiovascular disease and
mortality also in the Korean population. About one third of Korean adults aged 30 years or older are estimated to
have hypertension, and the prevalence of hypertension gradually increases as the age increases. The awareness,
treatment, and control rates of hypertension are generally improving in Korea, but more efforts are required to
increase awareness and treatment among younger patients with hypertension and to improve lifestyle modification
compliance at all ages. More studies are required to determine the magnitude and impact of white coat
hypertension and masked hypertension in the Korean population.
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Classification of blood pressure and hypertension
This guideline defines ‘hypertension (HTN)’ as a blood
pressure (BP) above the threshold value for which the
effectiveness of pharmacological treatment has been
proved by randomized clinical trials and also classifies
BP values lower than the threshold value based on car-
diovascular (CV) risk for using lifestyle modifications to
lower BP and prevent HTN. Therefore, based on the
available evidence from clinical trials, HTN is defined as
systolic blood pressure (SBP) ≥140mmHg or diastolic
blood pressure (DBP) ≥90 mmHg. HTN is further classi-
fied into grade 1 and grade 2 HTN depending on the
higher SBP or DBP value. ‘Normal BP’ is defined only as
both SBP below 120mmHg and DBP below 80mmHg.
Normal BP defines the optimal condition with the lowest
CV risk and is used as a reference when assessing the
risks of higher BP [1]. When an individual’s SBP is 120 to
129mmHg and the DBP is lower than 80mmHg, the indi-
vidual is considered to have ‘elevated BP’. Individuals with
a SBP of 130 to 139mmHg or a DBP of 80 to 89mmHg
are considered to have ‘prehypertension’. When an indi-
vidual’s SBP is greater than or equal to 140mmHg but
DBP is below 90mmHg, the patient is considered to have
‘isolated systolic HTN’ (Table 1).
High blood pressure and risk of cardiovascular
disease
It is well known that higher BP levels are associated with
increased risk of cardiovascular disease (CVD) and mor-
tality. In the Korean Medical Insurance Corporation
(KMIC) study, individuals with SBP/DBP greater than or
equal to 140/90mmHg showed 2.6-fold higher risk of
cerebrovascular disease and coronary artery diseases
(CAD), compared to those with SBP/DBP below than
130/85 mmHg [2, 3]. In a case-control study within the
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KMIC cohort, higher BP was the most contributable risk
factor to cerebrovascular disease and was associated with
the risk of CAD [3, 4]. Both Western and Asian studies
have shown that individuals with elevated BP or prehy-
pertension tend to have a worse lifestyle compared to
those with normal BP. In addition, the probability of
progressing to HTN and the risk for a CV event were
higher in the elevated BP or prehypertension groups than
those in the normal BP group [5–7]. In a large-scale
pooled cohort study of Asians, including many Koreans,
HTN was an important risk factor for the development of
stroke and ischemic heart disease [8]. The study also pre-
dicted that stroke prevention by BP control would be
much greater in Asian populations, since the risk of stroke
was reduced by 41% in Asians and 30% in Caucasians
when SBP was 10mmHg lower [1]. As shown in Fig. 1,
the attributable risks to HTN for cerebrovascular disease
and CAD in Korean men were 35 and 21%, respectively.
In addition, for each 20mmHg increase in SBP, the
relative risks of ischemic stroke, intracerebral hemorrhage,
and subarachnoid hemorrhage were 1.79, 2.48, and
1.65, respectively, in men and 1.64, 3.15, and 2.29, re-
spectively, in women [9]. Therefore, the contribution
of HTN to stroke and CAD has been well established
in Korean studies, and stroke is strongly associated
with HTN.
Prevalence of hypertension and distribution of
blood pressure
Prevalence of hypertension
Since 1998, the Korean National Health and Nutrition
Examination Survey (KNHANES) has measured resting
upper arm BP for a representative sample of the Korean
population and has defined HTN as SBP ≥140 mmHg,
DBP ≥90mmHg or taking antihypertensive medications.
The age-standardized prevalence of HTN is approxi-
mately 30% among adults aged 30 years or older.
Changes in the prevalence of hypertension
As shown in Table 2, the age-adjusted prevalence of
HTN from the KNHANES decreased from 29.8% in
1998 to 25.9% in the years 2007–2009 then increased
again up to 29.1% (men 35.0%, women 22.9%) in 2016
[10, 11]. In addition, 25.9% of individuals (men 30.8%,
women 20.8%) have elevated BP or prehypertension.
Thus, 55% of Koreans aged 30 years or older have
higher than normal BP. This percentage increases to
65.2% (men 61.7%, women 67.7%) among individuals
aged 65 years or older, and increases further in women
compared to men.





Normal blood pressurea < 120 And < 80
Elevated blood pressure 120–129 And < 80
Prehypertension 130–139 Or 80–89
Hypertension Grade 1 140–159 Or 90–99
Grade 2 ≥160 Or ≥100
Isolated systolic
hypertension
≥140 And < 90
aBlood pressure with minimal risk for cardiovascular events
Fig. 1 Attributable risks of major cardiovascular risk factors for cerebrovascular disease and coronary artery disease in Korean men (Source: Korean
Medical Insurance Corporation study)
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Age and sex differences in blood pressure
As the age increases, BP increases gradually, and the
prevalence of HTN exceeds 50% at age 60 and over
(Fig. 2) [12]. In the KNHANES 2016, the prevalence of
HTN was 50.9% among individuals aged 60–69 years and
69.2% among individuals aged 70 years or older. The preva-
lence was higher in men (55.9%) than in women (46.2%)
until the age of 60, but lower in men (64.2%) than in
women (72.2%) after age 70. In addition, SBP continues to
increase with age, but DBP begins to decline after age 60,
thus the pulse pressure, defined as the difference between
SBP and DBP, increases in the elderly population.
Salt intake and blood pressure
It is known that reducing salt intake can lower BP. The
daily intake of salt in Koreans is estimated to be over 10
g, so it is important to reduce salt intake to prevent
HTN [13]. According to an analysis of the 1998, 2001,
and 2005 KNHANES data, younger patients with hyper-
tension (aged less than 40 years) consumed more salt
than older patients with hypertension, but there was no
significant difference after adjusting for total energy intake
[14–16]. However, an independent association between salt
intake and BP was reported among individuals with meta-
bolic syndrome [14–17]. In addition, the urinary sodium/
creatinine ratio was more closely associated with the BP
level than the salt intake [18]. Since the KNHANES evalu-
ated salt intake with food questionnaires, the accuracy of
individual salt intake is limited. Also, since the KNHANES
is a cross-sectional study, it is not known whether diet has
changed after the diagnosis of hypertension. More research
is needed to understand the impact of salt intake on high
blood pressure in the Korean population. Because the salt
intake in KNHANES was estimated by using a food
questionnaire, which has limited accuracy, and because
it was a cross-sectional analysis including both patients
with HTN who had not yet changed their diet as well
as those who changed their eating habits after diagno-
sis, additional research is needed. According to studies
in other countries, a reduction of salt intake is effective
to lower BP regardless of the cross-sectional association
between salt intake and BP [19].
Metabolic syndrome and hypertension
Using the criteria for abdominal obesity as a waist
circumference of greater than 90 cm for men and 80 cm
for women, the prevalence of metabolic syndrome was
24.1% in the 1998–2005 KNHANES [20]. The preva-
lence of metabolic syndrome in Korean adults increased
from 28.8 to 30.5% during the period from 2009 to 2013,
and the increase in abdominal obesity was noticeable
[21]. Among the components of the metabolic syn-
drome, high BP is the most common in men (40%), but
low HDL-cholesterol level (59%) is the most common,
followed by HTN (30%), in women [22]. Based on the
data from the 2001 and 2005 KNHANES, the prevalence
of metabolic syndrome was 53.3% in patients with HTN
and 26.2% in people with elevated BP or prehyperten-
sion, both of which were significantly higher than the
24.1% prevalence in the general population [23]. Meta-
bolic disorder is a determinant of progression from pre-
hypertension to overt HTN [24, 25], thus, individuals
with metabolic syndrome are the key targets for lifestyle
modification.
Table 2 Trends in the prevalence of hypertension in the
population aged ≥30 years (Source: KNHANES)a
Category 1998 2001 2005 2007–09 2010–12 2013–15 2016
All 29.8% 28.5% 28.0% 25.9% 28.0% 26.8% 29.1%
Men 32.4% 33.2% 31.5% 28.8% 31.4% 31.6% 35.0%
Women 26.8% 25.3% 23.8% 22.7% 24.2% 22.0% 22.9%
aAge-standardized values were calculated using the age structures of the 2005
Korean population
Fig. 2 Prevalence of hypertension by sex and age (Source: 2016 KNHANES)
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Management of hypertension
It is important to monitor the rates of awareness, treat-
ment, and control of HTN, as these are the key indica-
tors of the quality of HTN management. The awareness
rate is defined as the proportion of the subjects who are
aware of their physician-diagnosed HTN among all of
the subjects with HTN. The treatment rate is defined as
the proportion of the subjects taking antihypertensive
drugs at the time of the survey among all of the subjects
with HTN. The control rate is defined as the proportion
of the subjects with SBP/DBP controlled below 140/90
mmHg among the subjects taking antihypertensive drugs
or among all subjects with HTN.
The awareness, treatment, and control rates of hyper-
tension in South Korea are generally improving. Accord-
ing to the data from KNHANES, the awareness rate
among HTN patients aged 30 years or older increased
from 25% in 1998 to 65% in 2016. The treatment rate
also improved significantly from 22% in 1998 to 61% in
2016. During the same period, the control rate increased
from 5 to 44% among all patients with HTN, and from
24 to 71% among patients taking antihypertensive drugs
(Table 3). Although the prevalence of HTN in Korea has
not changed much over the past 30 years, the average BP
level has steadily decreased, especially among patients
with HTN, which has led to the reduction in the mean
BP of the entire population [10].
The changes in these indicators suggest that the over-
all management of HTN has improved over the past few
decades. However, the rates of awareness, treatment, and
control are still low among younger patients with HTN,
more specifically those in the 30s to 40s age groups.
According to the 2016 KNHANES data, HTN awareness
rates of individuals in their 30s and 40s are 17.1 and
42.4%, treatment rates are 15.0 and 35.3%, and the con-
trol rates are 8.0 and 26.0%, respectively. Although the
control rates for all HTN patients is much lower in the
younger age group than in the older group, but the con-
trol rate for treated HTN patients does not differ among
age groups, this implies that early detection and treat-
ment of HTN in younger individuals is important.
According to the 2007 KNHANES data, the proportion
of individuals actively performing three or more of the
listed lifestyle modifications (weight control, regular
exercise, moderation of alcohol intake, reduction of salt
intake, and smoking cessation) was only 38.2% among pa-
tients with HTN aged 40 years or older. More efforts are
required to improve lifestyle modification compliance.
White coat hypertension and masked
hypertension
‘White coat HTN’ is diagnosed when the patient’s BP in
the doctor’s office is 140/90 mmHg or above but the
daytime ambulatory BP or home BP is less than 135/85
mmHg. If the BP is high both in and out of the office,
the patient is considered to have persistent HTN. Ac-
cording to the registry data for ambulatory BP monitor-
ing (ABPM) in secondary or tertiary referral centers
supported by the Korean Society of Hypertension (Kor-
ABP registry), 14.9% of 1916 subjects who underwent
ABPM for the diagnosis of HTN were found to have
white coat HTN. In a single-center study from a domes-
tic tertiary hospital, white coat HTN occurred more fre-
quently in women and in men with a low body mass
index (BMI) [26]. According to the KorABP registry
data, the proportion of subjects in whom daytime ambu-
latory BP was lower than 135/85 mmHg and office BP
higher than 140/90 mmHg was 13.5% among all treated
subjects and 21.3% among subjects with uncontrolled
HTN by office BP [27].
‘Masked HTN’ is defined as the condition in which the
office BP is less than 140/90mmHg and the daytime am-
bulatory BP or home BP is 135/85mmHg or higher. Ac-
cording to the KorABP registry data, masked HTN was
observed in 17.6% of patients who underwent ABPM for
the diagnosis of HTN. Masked HTN was also observed in
13.8% of patients taking antihypertensive medication and
in 35.1% of subjects with controlled office BP [27].. In a
Korean study performed in primary care clinics, the
prevalence of masked HTN was 21.2%, and male sex,
older age, and smoking were the independent predictors
of masked HTN [28]. A study of patients at a tertiary care
center reported that the number of pills and higher fasting
blood glucose are associated with masked HTN [29].
There is no available data on white coat HTN and
masked HTN in the general Korean population. Accord-
ing to data from other countries, patients with white coat
HTN have a relatively good short-term clinical course.
However, white coat HTN can develop into persistent
HTN and increase the risk of CVD in the long-term,
Table 3 Trends in awareness, treatment, and control rate of hypertension (Source: KNHANES)a
Parameter 1998 2001 2005 2007–09 2010–12 2013–15 2016
Awareness rate 25% 34% 57% 65% 63% 64% 65%
Treatment rate 22% 32% 50% 59% 58% 60% 61%
Control rate for all hypertension patients 5% 12% 27% 41% 40% 43% 44%
Control rate for treated hypertension patients 24% 38% 55% 69% 69% 72% 71%
aAge-standardized values were calculated using the age structures of the 2005 Korean population
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therefore, patients with white coat HTN should be moni-
tored regularly [30]. In foreign studies, masked HTN has a
similar [31, 32] or worse [33] prognosis, compared to per-
sistent HTN. A Korean study reported more severe myo-
cardial damage in patients with masked HTN than in
those with white coat HTN [34].
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